NBI® and benign lesions of laryngeal mucosa

Chapter 45

  • Krzysztof Izdebski
  • Raul M. Cruz
Keywords: NBI®, VF, dysphonias, efficacy, WL, vascular blush, neovascularization, benign phonatory lesions, vascularity, B-nodes, vocal fatigue, CUG

Abstract

NBI® technology has only recently been applied to observe laryngeal pathology and it is being used predominantly when examining cases suspicious for malignancy or for RRP. However, many other pathological conditions in the larynx feature abnormal vascular components. This group of dysphonias includes benign laryngeal conditions. Hence, we report here on how NBI® exposes benign lesions of the laryngeal mucosa and leads to improved diagnosis and management of dysphonias.

Published
2016-06-02